CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
Provided By GlobeNewswire
Last update: Nov 12, 2024
- Late-Breaking Abstract on Results of Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in BCG-Unresponsive NMIBC Accepted at the Society of Urologic Oncology (SUO) 25th Annual Meeting -
Read more at globenewswire.com
